Bonus Biogroup (BONS) — Capital Reinvestment Ratio

Latest as of December 2008: 0.76x

Bonus Biogroup (BONS) has a Capital Reinvestment Ratio of 0.76x as of December 2008, meaning it reinvests 1% of its operating cash flow (ILA20.52 Million) in capital expenditures (ILA15.67 Million). See cash generation quality of Bonus Biogroup to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.76x
Capex / Operating Cash Flow

Operating Cash Flow

ILA20.52 Million
ILA

Capital Expenditures

ILA15.67 Million
ILA

Data as of

Dec 2008
Most recent filing

Bonus Biogroup Capital Reinvestment Ratio (2008–2008)

This chart tracks Bonus Biogroup's Capital Reinvestment Ratio across 1 annual periods.

Annual Capital Reinvestment Ratio for Bonus Biogroup (2008–2008)

Year-by-year Capital Reinvestment Ratio for Bonus Biogroup from 2008 to 2008. For live market cap and broader valuation context, see Bonus Biogroup stock valuation.

Year Reinvestment Ratio Operating CF (ILA) Capital Expenditures YoY Change
2008 0.76x ILA20.52 Million ILA15.67 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow